1 of 1
Story summary
- Kratom exposure calls to poison centers rose 1,200% from 2015 to 2025, totaling 14,400 reports.
- Most cases involve men in their 20s–30s, with ages 40–59 rising.
- Hospitalizations tied to kratom rose from 43 to 538, and multi-substance cases rose nearly 1,300%.
- The U.S. Food and Drug Administration (FDA) aims to classify 7-hydroxymitragynine as Schedule I due to abuse potential.
- The American Kratom Association now supports regulating kratom products.
